Can mycotoxins amplify allergic and mast-cell reactivity?

Exposure to environmental mycotoxins can initiate a cascading pathological response in mucosal and epithelial tissues, driving localized inflammation and systemic immune sensitivity.

Cellular and barrier disruption

• Oxidative stress and mitochondrial injury: Mycotoxins such as zearalenone, fumonisin B1, and patulin trigger rapid reactive oxygen species (ROS) accumulation and mitochondrial damage in epithelial and endothelial cells.
• Epithelial barrier degradation: These toxins directly compromise mucosal integrity by significantly reducing transepithelial electrical resistance (TEER) and downregulating crucial tight junction proteins, specifically ZO-1, occludin, and claudins.

Amplification of mast-cell reactivity

• Pathways of activation: Elevated ROS levels act as a critical signaling node, modulating intracellular calcium flux and ERK1/2 pathways to stimulate mast cell degranulation. Concurrently, epithelial-derived innate alarmins like IL-33 and Toll-like receptor (TLR) signaling directly recruit and activate mast cells.
• Pathogenic feedback loop: The resulting barrier dysfunction permits increased penetration of luminal antigens. Once activated, mast cells release mediators like histamines and proteases (including tryptase and chymase) that further degrade tight junction proteins, establishing a self-reinforcing cycle of barrier permeability and immune hyperreactivity.

Bottom line

• Bottom line: Strong scientific evidence supports that mycotoxins (zearalenone, fumonisins, and patulin) impair epithelial barriers and induce oxidative stress, creating a self-reinforcing feedback loop that directly amplifies mast-cell activation and allergic reactivity.